Aller au contenu principal
Accès ouvert déclaré 2025 article

Prophylactic Antiseizure Medication in Patients with Lobar Intracerebral Hemorrhage

2Citations signalées — pas une note de qualité
6Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

BACKGROUND: Early seizures are a common complication after acute intracerebral hemorrhage (ICH). We tested the hypothesis of whether prophylactic antiseizure medication is associated with lower incidence of early seizures in patients with elevated risk of ICH. METHODS: This study involved a retrospective analysis of a prospective observational cohort, including five academic medical centers with a focus on patients presenting spontaneous ICH on hospital admission in the years 2006 through 2023. We assessed the characteristics of acute ICH and the administration of antiseizure medication. In this observational cohort, the administration of antiseizure medication was at the discretion of the treating physician. We focused on the 300 patients with lobar hematoma location. Age, hematoma volume, and sex were included as covariates in an adjusted regression model to evaluate seizure occurrence. We prospectively recorded the use of antiseizure medications and identified the occurrence of early seizures. Additionally, we conducted an exploratory analysis defining patients who were at risk as those with lobar hematomas, age < 65 years, and hematoma volume ≥ 10 mL. Functional outcomes were assessed using modified Rankin Scale scores three months after event. RESULTS: The median age was 72.0 (interquartile range 62.0-80.0) years, and 158 (53%) were female. An early seizure occurred in 43 (14.3%). In patients who did not receive antiseizure prophylaxis, 34 of 157 (21.6%) had an early seizure, whereas in patients who did receive antiseizure prophylaxis, 9 of 143 (6.3%) had an early seizure. Prophylactic antiseizure medication was associated with a reduced incidence of early seizures (adjusted odds ratio 0.25, 95% confidence interval 0.11-0.54, P = 0.0005) in patients at high risk for early seizures. There was no association between prophylactic medication use and modified Rankin Scale scores at three-month follow-up. CONCLUSIONS: In a retrospective analysis of a multicenter cohort of patients at elevated seizure risk after ICH, prophylactic antiseizure medication was associated with a reduced likelihood of an early seizure.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Prophylactic Antiseizure Medication in Patients with Lobar Intracerebral Hemorrhage
Date Crossref
18/12/2025
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Intracerebral and Subarachnoid Hemorrhage ResearchEpilepsy research and treatmentTraumatic Brain Injury and Neurovascular Disturbances

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.